Related Experiment Video
Updated: Apr 20, 2026

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
Published on: June 16, 2019
Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway
Jisun Lee1, Seul Lee1, Sun-Lim Kim2
1Department of Biotechnology, The CUK Agromedical Research Center, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Republic of Korea.
Aims:
Despite recent advances in prostate cancer diagnostics and therapeutics, the overall survival rate still remains low. This study was aimed to assess potential anti-cancer activity of maysin, a major flavonoid of corn silk (CS, Zea mays L.), in androgen-independent human prostate cancer cells (PC-3).
Main Methods:
Maysin was isolated from CS of Kwangpyeongok, a Korean hybrid corn, via methanol extraction and preparative C18 reverse phase column chromatography. Maysin cytotoxicity was determined by either monitoring cell viability in various cancer cell lines by MTT assay or morphological changes. Apoptotic cell death was assessed by annexin V-FITC/PI double staining, depolarization of mitochondrial membrane potential (MMP), expression levels of Bcl-2 and pro-caspase-3 and by terminal transferase mediated dUTP-fluorescein nick end labeling (TUNEL) staining. Underlying mechanism in maysin-induced apoptosis of PC-3 cells was explored by evaluating its effects on Akt and ERK pathway.
Key Findings:
Maysin dose-dependently reduced the PC-3 cell viability, with an 87% reduction at 200 μg/ml. Maysin treatment significantly induced apoptotic cell death, DNA fragmentation, depolarization of MMP, and reduction in Bcl-2 and pro-caspase-3 expression levels. Maysin also significantly attenuated phosphorylation of Akt and ERK. A combined treatment with maysin and other known anti-cancer agents, including 5-FU, etoposide, cisplatin, or camptothecin, synergistically enhanced PC-3 cell death.
Significance:
These results suggested for the first time that maysin inhibits the PC-3 cancer cell growth via stimulation of mitochondria-dependent apoptotic cell death and may have a strong therapeutic potential for the treatment of either chemo-resistant or androgen-independent human prostate cancer.
Insights
Maysin, a corn silk flavonoid, effectively inhibits prostate cancer cell growth by inducing apoptosis. This natural compound shows significant therapeutic potential for chemo-resistant and androgen-independent prostate cancer.
Area of Science:
- Natural Product Chemistry
- Cancer Biology
- Molecular Pharmacology
Background:
- Prostate cancer survival rates remain low despite therapeutic advances.
- Androgen-independent prostate cancer (PC-3 cells) presents a significant clinical challenge.
- Corn silk (Zea mays L.) contains maysin, a flavonoid with potential anti-cancer properties.
Purpose of the Study:
- To investigate the anti-cancer activity of maysin in androgen-independent human prostate cancer cells (PC-3).
- To elucidate the mechanism of maysin-induced cell death.
Main Methods:
- Maysin isolation from corn silk using methanol extraction and chromatography.
- Cytotoxicity assessment via MTT assay and morphological analysis.
- Apoptosis evaluation using Annexin V-FITC/PI staining, mitochondrial membrane potential (MMP) assessment, Bcl-2 and pro-caspase-3 expression analysis, and TUNEL staining.
- Exploration of signaling pathways (Akt and ERK) involved in maysin-induced apoptosis.
Main Results:
- Maysin demonstrated dose-dependent cytotoxicity against PC-3 cells, achieving 87% viability reduction at 200 μg/ml.
- Maysin significantly induced apoptosis, characterized by DNA fragmentation, MMP depolarization, and altered Bcl-2/pro-caspase-3 levels.
- Maysin treatment attenuated Akt and ERK phosphorylation, suggesting pathway involvement.
- Combined treatment with maysin and conventional chemotherapeutics showed synergistic effects on PC-3 cell death.
Conclusions:
- Maysin inhibits PC-3 cancer cell growth through the induction of mitochondria-dependent apoptotic cell death.
- Maysin exhibits significant therapeutic potential for treating chemo-resistant and androgen-independent prostate cancer.
- This study provides the first evidence of maysin's efficacy and mechanism in prostate cancer cells.
More Related Videos
08:31Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis